New guidelines and best practices may lead to improved quality and reduced recalls due to visual defects. Improving understanding and practice of visual inspection of parenteral drugs is a high ...
As a mandatory practice for injectable drug products by both FDA and the European Medicines Agency to ensure patient safety, visual inspection identifies and rejects parenteral containers and units ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback